Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study.

MLA

Motovska, Zuzana, et al. “Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study.” Circulation, vol. 134, no. 21, Nov. 2016, pp. 1603–12. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.116.024823.

APA

Motovska, Z., Hlinomaz, O., Miklik, R., Hromadka, M., Varvarovsky, I., Dusek, J., Knot, J., Jarkovsky, J., Kala, P., Rokyta, R., Tousek, F., Kramarikova, P., Majtan, B., Simek, S., Branny, M., Mrozek, J., Cervinka, P., Ostransky, J., Widimsky, P., & PRAGUE-18 Study Group. (2016). Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study. Circulation, 134(21), 1603–1612. https://doi.org/10.1161/CIRCULATIONAHA.116.024823

Chicago

Motovska, Zuzana, Ota Hlinomaz, Roman Miklik, Milan Hromadka, Ivo Varvarovsky, Jaroslav Dusek, Jiri Knot, et al. 2016. “Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study.” Circulation 134 (21): 1603–12. doi:10.1161/CIRCULATIONAHA.116.024823.